Prosecution Insights
Last updated: May 29, 2026
Application No. 17/026,844

SYSTEM AND METHOD FOR DETERMINING SLEEP STAGES BASED ON NON-CARDIAC BODY SIGNALS

Non-Final OA §101
Filed
Sep 21, 2020
Priority
Sep 20, 2019 — provisional 62/903,493 +1 more
Examiner
AGAHI, PUYA
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Nox Medical Ehf
OA Round
8 (Non-Final)
49%
Grant Probability
Moderate
8-9
OA Rounds
0m
Est. Remaining
72%
With Interview

Examiner Intelligence

Grants 49% of resolved cases
49%
Career Allowance Rate
255 granted / 523 resolved
-21.2% vs TC avg
Strong +24% interview lift
Without
With
+23.6%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
41 currently pending
Career history
587
Total Applications
across all art units

Statute-Specific Performance

§101
13.4%
-26.6% vs TC avg
§103
69.2%
+29.2% vs TC avg
§102
3.4%
-36.6% vs TC avg
§112
3.9%
-36.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 523 resolved cases

Office Action

§101
DETAILED ACTION Note: The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicant’s arguments filed in the reply on October 30, 2025 were received and fully considered. Claims 31-35 are new. No claims were amended. The current action is FINAL. Please see corresponding rejection headings and response to arguments section below for more detail. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-5, 9-15, and 19-35 are rejected under 35 U.S.C. 101 because the claimed invention is directed to non-statutory subject matter. The claim(s) as a whole, considering all claim elements both individually and in combination, do not amount to significantly more than an abstract idea. A streamlined analysis of claim 1 follows. Regarding claim 1, the claim recites a series of steps or acts for determining a sleep stage of a subject. Thus, the claim is directed to a process, which is one of the statutory categories of invention. The claim is then analyzed to determine whether it is directed to any judicial exception. The following limitations set forth a judicial exception: “...extracting one or more features from the thoracic RIP signal and from the abdomen RIP signal; determining the sleep stage of the subject based on the one or more features extracted from the thoracic RIP signal and from the abdomen RIP signal by performing a computer-based classification of the one or more features extracted from the thoracic RIP signal and from the abdomen RIP signal using a classifier, wherein the classifier is a neural network, decision tree or trees, forests of decision trees, clustering, and/or a support vector machine, wherein the one or more extracted features used in the computer-based classification include one or more of a respiratory rate or respiratory rate variability, a first harmonic or a DC component of a respiratory rate, a harmonic of the respiratory rate, a breath-by-breath characteristic, a breath amplitude, a breath length, a zero-flow ratio, RIP phase, skewness of breaths, max flow in, max flow out, a ratio of max flow in and max flow out, a time constant of inhalation and/or exhaustion, an abdomen respiratory volume signal, a thorax respiratory volume signal, a sum of the abdomen and thorax respiratory volume signal (RIPSum), a time derivative of a sum of the abdomen respiratory volume signal and the thorax respiratory volume signal (RIPflow), or a respiratory phase signal (Phase) indicating a phase difference between the abdomen respiratory volume signal and the thorax respiratory volume signal, or mean and standard deviations, or difference mean ratios thereof, and wherein the sleep stage of the subject is determined without using either cardio or heart-based features of a signal of the subject and without using a cardio or heart-based signal of the subject.” These limitations describe a mathematical calculation. Furthermore, the limitations describe a mental process as the skilled artisan is capable of analyzing conventional RIP signals (e.g. from a computer readout) and making a mental assessment thereafter. Furthermore, nothing from the claims, as currently recited, suggest that the skilled artisan could not practically perform the identified judicial exception mentally, or using simple pen/paper. Next, the claim as a whole is analyzed to determine whether any element, or combination of elements, integrates the identified judicial exception into a practical application. For this part of the 101 analysis, the following additional limitations are considered: “...obtaining by a processor one or more respiratory signals, the one or more respiratory signals being an indicator of a respiratory activity of the subject, the one or more respiratory signals including a thoracic respiratory inductance plethysmography (RIP) signal and an abdomen respiratory inductance plethysmography (RIP) signal...” These additional limitations do not integrate the judicial exception into a practical application. Rather, the additional limitations amount to insignificant pre-solution activity, e.g., mere data gathering steps necessary to perform the mental process. Moreover, the recited processor does not integrate the claims into a practical application because “use of a machine that contributes only nominally or insignificantly to the execution of the claimed method (e.g., in a data gathering step . . . ) would not integrate a judicial exception.” See MPEP 2106.05(b)(III). Furthermore, the additional limitations do not add significantly more to the identified judicial exception as they amount to obtaining widely known types of physiological signals and a generically recited processor. Moreover, the recited processor does not amount to significantly more because a general-purpose processor that merely executes the judicial exception is not a particular machine. See Ultramercial, Inc. v. Hulu, LLC, 772 F.3d 709, 706-17 (Fed. Cir. 2014), cited in MPEP § 2106.05(b)(I). Independent claims 11 and 20 are also not patent eligible for substantially similar reasons. Dependent claims 2-5, 9, 10, 12-15, and 21-35 also fail to add something more to the abstract independent claims as they merely further limit the abstract idea, recite limitations that do not integrate the claims into a practical application for substantially similar reasons as set forth above, and/or do not recite significantly more than the identified abstract idea for substantially similar reasons as set forth above. Therefore, claims 1-5, 9-15, and 19-35 are not patent eligible under 35 USC 101. Response to Arguments Applicant's arguments filed with respect to the 35 USC 101 rejections raised in the previous office action have been fully considered, but they are not persuasive. Examiner maintains that the claims recite an abstract idea (mathematical calculations and/or mental process) that is (1) not integrated into a practical application; and (2) the additional limitations (generically recited processor) do not recite significantly more. Applicant’s argument that the claims cannot be practically performed by a skilled artisan is also not persuasive as nothing from the claims suggest that the skilled artisan would not be able to perform the recited steps mentally, or with simple pen/paper. In any case, Examiner maintains that the claims recite mathematical calculations. See also 2024 AI SME update, which establishes that a trained neural network, as is similarly and more generically recited in the instant claims, amounts to a series of mathematical calculations1. Applicant also appears to argue that the instant claims recite an improvement, i.e. solve the technical problem of determining sleep stages without using other signals (EEG). However, this is not persuasive as the purported improvement appears to lie within the judicial exception itself, which would not amount to significantly more2. Applicant goes onto argue that determining the sleep stage integrates the judicial exception into a practical application as it “changes the method from a simple calculation of values to an actual practical application” (remarks, pg. 18). Examiner respectfully disagrees as “wherein the sleep stage of the subject is determined…”, as recited in claim 1, is part of the judicial exception. In any case, and should applicant positively incorporate an outputting step (e.g. display), this would also not integrate the claims into a practical application3. For at least these reasons, the 35 USC 101 rejections are maintained. Conclusion No claim is allowed. THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to PUYA AGAHI whose telephone number is (571)270-1906. The examiner can normally be reached M-F 8 AM - 5 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alexander Valvis can be reached at 5712724233. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PUYA AGAHI/Primary Examiner, Art Unit 3791 1 See Claim 2 from Example 47, which held that a trained neural network amounts to mathematical calculations and/or a mental process. https://www.uspto.gov/sites/default/files/documents/2024-AI-SMEUpdateExamples47-49.pdf 2 “the judicial exception alone cannot provide the improvement.” See the discussion of Diamond v. Diehr, 450 U.S. 175, 187 and 191-92, 209 USPQ 1, 10 (1981). 3 MPEP 2106.05(g) Insignificant Extra-Solution Activity… data gathering and outputting
Read full office action

Prosecution Timeline

Show 15 earlier events
Apr 30, 2025
Non-Final Rejection mailed — §101
Sep 09, 2025
Examiner Interview Summary
Sep 09, 2025
Applicant Interview (Telephonic)
Oct 30, 2025
Response Filed
Nov 13, 2025
Final Rejection mailed — §101
May 13, 2026
Request for Continued Examination
May 18, 2026
Response after Non-Final Action
May 26, 2026
Non-Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12635905
EXHALED BREATH CONDENSATE COLLECTION DEVICE AND A KIT OF PARTS THEREFOR
4y 1m to grant Granted May 26, 2026
Patent 12629066
USE OF SENSOR REDUNDANCY TO DETECT SENSOR FAILURES
5y 5m to grant Granted May 19, 2026
Patent 12623019
SYSTEM, METHOD, AND COMPUTER READABLE MEDIUM FOR DYNAMIC INSULIN SENSITIVITY IN DIABETIC PUMP USERS
6y 7m to grant Granted May 12, 2026
Patent 12616385
FLUID CIRCUIT AND BLOOD PRESSURE MEASUREMENT DEVICE
3y 7m to grant Granted May 05, 2026
Patent 12594002
DEVICE FOR MONITORING THE HEALTH OF A PERSON
6y 2m to grant Granted Apr 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

8-9
Expected OA Rounds
49%
Grant Probability
72%
With Interview (+23.6%)
4y 2m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 523 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month